 Myasthenia gravis mothers newborns Myasthenia gravis complex autoimmune disorder Anti-AChR antibodies elements postsynaptic membrane myoneural junction affected muscle groups results decreased nerve-impulse transmission Myasthenic patients skeletal muscle strength tire exercise Pregnancy maternal myasthenic exacerbation crisis puerperium medication frequent adjustment pregnancy due requirements physiologic changes absorption excretion Myasthenia results increase maternal mortality morbidity pregnancy wastage premature labor Anticholinesterase medications corticosteroids mainstays medical therapy maternal Thymectomy plasmapheresis immunosuppressant drugs gamma globulin ACTH adjuvants usefulness Enforced rest periods tranquil environment prompt treatment intercurrent infections important myasthenic mothers management myasthenic crisis hospital intensive care mechanical respiratory support careful monitoring blood gases Plasmapheresis effective means crises intensive steroid immunosuppressant therapy myasthenic mother undertakes pregnancy risk infant chance exacerbation MG pregnancy additional risk puerperium Maternal mortality risk live births Perinatal mortality births times uncomplicated pregnancies Modern management risks extent pregnancy myasthenic women good outcome meticulous maternal fetal prenatal surveillance early detection management exacerbations Facilities trained personnel available labor manage vaginal operative delivery Intensive care myasthenic crises critical prevention maternal complications death